QCM
DGX icon

Quantinno Capital Management’s Quest Diagnostics DGX Stock Holding History

Quantinno Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.3M Sell
231,025
-38,572
-14% -$7.49M 0.08% 305
2025
Q4 		$46.8M Buy
269,597
+76,083
+39% +$13.9M 0.09% 220
2025
Q3 		$36.9M Buy
193,514
+141,838
+274% +$25.2M 0.1% 224
2025
Q2 		$9.28M Buy
51,676
+24,259
+88% +$4.21M 0.04% 558
2025
Q1 		$4.64M Buy
27,417
+8,464
+45% +$1.39M 0.03% 682
2024
Q4 		$2.86M Buy
18,953
+10,688
+129% +$1.66M 0.03% 711
2024
Q3 		$1.28M Buy
8,265
+2,209
+36% +$330K 0.02% 864
2024
Q2 		$829K Buy
6,056
+2,034
+51% +$279K 0.01% 872
2024
Q1 		$535K Sell
4,022
-881
-18% -$114K 0.01% 934
2023
Q4 		$676K Buy
4,903
+2,315
+89% +$304K 0.02% 735
2023
Q3 		$315K Sell
2,588
-6,399
-71% -$853K 0.01% 864
2023
Q2 		$1.26M Sell
8,987
-1,445
-14% -$199K 0.07% 359
2023
Q1 		$1.48M Sell
10,432
-13,331
-56% -$1.91M 0.1% 274
2022
Q4 		$3.72M Buy
23,763
+12,090
+104% +$1.74M 0.28% 55
2022
Q3 		$1.43M Buy
11,673
+1,863
+19% +$245K 0.18% 136
2022
Q2 		$1.3M Buy
9,810
+3,001
+44% +$409K 0.19% 143
2022
Q1 		$932K Buy
6,809
+3,511
+106% +$489K 0.14% 182
2021
Q4 		$571K Buy
+3,298
New +$502K 0.1% 235
2020
Q2 		– Sell
-5,972
Closed -$480K – 344
2020
Q1 		$480K Buy
5,972
+2,362
+65% +$245K 0.3% 153
2019
Q4 		$386K Sell
3,610
-3,126
-46% -$326K 0.24% 178
2019
Q3 		$721K Buy
+6,736
New +$692K 0.49% 17

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Quantinno Capital Management's DGX Position: Q1 2026 in Review

Quantinno Capital Management reduced its Quest Diagnostics (DGX) stake by 14% in Q1 2026, selling an estimated $7.49M and leaving 231,025 shares worth $45.3M. The position accounts for 0.08% of the portfolio, ranked #305.

Quantinno Capital Management first reported a position in DGX in Q3 2019 and has held it in 21 quarters since. The position peaked at $46.8M in Q4 2025. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Quantinno Capital Management held 231,025 shares of Quest Diagnostics worth $45.3M as of Q1 2026.
  • Quantinno Capital Management sold 38,572 Quest Diagnostics shares in Q1 2026, an estimated $7.49M.
  • Quest Diagnostics made up 0.08% of Quantinno Capital Management's portfolio in Q1 2026, its #305 holding.
  • Quantinno Capital Management first reported a position in Quest Diagnostics in Q3 2019 and has held it in 21 quarters since.
  • Quantinno Capital Management's Quest Diagnostics position peaked at $46.8M in Q4 2025.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.